FDA’s director of the Office of Dietary Supplement Programs (ODSP), Cara Welch, PhD, stopped by SupplySide East to present an overview of the agency’s FY23 activities related to dietary supplements and FY24 plans as well as an update on the pending Human Foods Program reorganization. She sat down with NutraIngredients-USA to discuss these topics and more.
The Brazilian Health Regulatory Agency (ANVISA) has approved Kyowa Hakko’s Setria ingredient, making it the first glutathione authorized for use in dietary supplements and functional foods in the country.
The Council for Responsible Nutrition has turned up the heat on FDA over its position that NAC is not a legal dietary ingredient. CRN asserts that the Agency has ignored a central legal question.
As the dietary supplement industry turns the corner to 2022, a range of challenges confronts us supply chain disruptions, staffing shortages, and inflationary pressures, to name a few. Some difficulties must be addressed individually, but I suggest the greatest challenge for the industry collectively is finding consensus on the issues that matter.
As the dietary supplement industry turns the corner to 2022, a range of challenges confronts us supply chain disruptions, staffing shortages, and inflationary pressures, to name a few. Some difficulties must be addressed individually, but I suggest the greatest challenge for the industry collectively is finding consensus on the issues that matter.